%0 Editorial
%T The evolution of the treatment of non-small cell lung cancer: A shift in surgical paradigm to a more individualized approach.
%A Li T
%A Zhang Y
%A Fu F
%A Chen H
%J J Thorac Cardiovasc Surg
%V 0
%N 0
%D 2024 Jul 25
%M 39067812
%F 6.439
%R 10.1016/j.jtcvs.2024.07.040
%X Surgical treatment is an integral part of the comprehensive therapeutic methods for lung cancer, especially for early-stage non-small cell lung cancer (NSCLC). With a deeper understanding of the disease, we found that lung cancer is more commonly detected in young females. For regions of Asia, more lung cancer has been detected in early-stage GGO-dominant non-smokers. Therefore, surgical strategies have also been reformed commensurate with the shift of the disease spectrum. However, the pursuit of lung-sparing individualized approaches has raised worldwide attention. Suitable surgical treatment within the curative time window is recommended to maximize the long-term benefit. This article summarizes the shift in surgical treatment for small NSCLCs and hopes to enlighten further innovations to fill in the gaps between the unmet needs and a more individualized approach.